MTA2 and adrenal cortex carcinoma: Consequently, we concluded that the expression of MTA2 was significantly associated with the OS of ACC (p = 0.025), BRCA (p = 0.025), ESCA (p = 0.04), KIRC (p = 0.032), LAML (p = 0.007), LIHC (p = 0.046), MESO (p = 0.016), and STAD (p = 0.026) (Figure 4A–H).